Media & Press relations

Our latest press releases

August 07, 2026

First-Half 2026 Results

bioMérieux's Q2 2026 sales totaled €981 million, with solid organic growth at +5%, reaching +7% excluding BIOFIRE® respiratory panels. The sales of the GO•28 growth drivers increased by 8.5% organically in Q2 26.

Discover more

Swipe for more

August 06, 2026

bioMérieux Highlights Positive Impacts of Rapid, Accurate Diagnostics for Patients and Accepts Industry Awards at ADLM 2026

bioMérieux hosted a press panel and accepted seven 2026 IMV ServiceTrak™ Clinical Laboratory Awards. These awards highlight bioMérieux’s continued commitment to delivering industry-leading diagnostic solutions and exceptional customer support to clinical laboratories.

Read more
July 13, 2026

bioMérieux to Showcase Company’s Latest in Diagnostic Innovations at ADLM 2026

bioMérieux announced it will showcase its latest diagnostic solutions and innovations at the 2026 Association for Diagnostics & Laboratory Medicine (ADLM) Annual Conference & Clinical Lab Expo.

Read more
July 06, 2026

WATCHFIRE^™ Solution now available for wastewater monitoring in the United States through BioFire Defense

Salt Lake City, Utah, July 6, 2026 – bioMérieux, a world leader in the field of in vitro diagnostics, announces that the WATCHFIRE^™ Solution multiplex PCR test for wastewater monitoring is now available through BioFire Defense, a bioMérieux affiliate company. WATCHFIRE^™ offers two panel tests that screen for more than 40 pathogens that cause respiratory and gastrointestinal illnesses with easy near-source testing offering multiple PCR results in about an hour.

Read more